INTRAVITREAL INJECTION OF ANTI-VEGF VERSUS PHOTODYNAMIC THERAPY FOR CNV ASSOCIATED WITH PATHOLOGICAL MYOPIA
عماد عفت صبرى;
Abstract
Pathological myopia is one of the leading causes of visual disability in the world from 20 to 50 years of age.
Prevalence rates of Pathological myopia vary between 2% and 9%, depending on the race and age of the population. It is characterized by axial
Prevalence rates of Pathological myopia vary between 2% and 9%, depending on the race and age of the population. It is characterized by axial
Other data
| Title | INTRAVITREAL INJECTION OF ANTI-VEGF VERSUS PHOTODYNAMIC THERAPY FOR CNV ASSOCIATED WITH PATHOLOGICAL MYOPIA | Other Titles | حقن مضادات تكوين أوعية دموية جديدة ومقارنتها بالعلاج الضوئى فى حالات قصر النظر الباثولوجى | Authors | عماد عفت صبرى | Keywords | INTRAVITREAL INJECTION OF ANTI-VEGF VERSUS PHOTODYNAMIC THERAPY FOR CNV ASSOCIATED WITH PATHOLOGICAL MYOPIA | Issue Date | 2011 | Description | Pathological myopia is one of the leading causes of visual disability in the world from 20 to 50 years of age. Prevalence rates of Pathological myopia vary between 2% and 9%, depending on the race and age of the population. It is characterized by axial |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 106822p4193.pdf | 483.28 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.